Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Synlogic advances SYNB-8802 into phase I study for treatment of enteric hyperoxaluria

Nov. 5, 2020

Phase III results for molidustat in patients with renal anemia undergoing dialysis

Nov. 4, 2020

dEF-3122 improves inflammation and fibrosis in liver and kidneys of NASH mice

Nov. 3, 2020

First-in-class LDHA inhibitor CHK-336 for treating primary hyperoxaluria

Nov. 3, 2020

Dimerix announces positive data from phase II ACTION trials of DMX-200 in kidney disease

Oct. 28, 2020

J2H Biotech, Ahn-Gook Pharmaceutical describe new mirabegron prodrugs

Oct. 28, 2020

NOX5 is a therapeutic target in diabetic kidney disease

Oct. 9, 2020

Patient screening ongoing in phase IIa study of IP-2018

Oct. 6, 2020

CSL begins phase II study of CSL-346 in diabetic kidney disease

Oct. 2, 2020

Positive topline phase I data for ROSgard in patients with renal impairment

Sep. 30, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...